These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19903421)

  • 1. Gastric infection by Helicobacter pylori.
    Sachs G; Wen Y; Scott DR
    Curr Gastroenterol Rep; 2009 Dec; 11(6):455-61. PubMed ID: 19903421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric infection by Helicobacter pylori.
    Sachs G; Scott DR; Wen Y
    Curr Gastroenterol Rep; 2011 Dec; 13(6):540-6. PubMed ID: 21993716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Rescue' therapies for the management of Helicobacter pylori infection.
    Di Mario F; Cavallaro LG; Scarpignato C
    Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Helicobacter pylori, a rediscovered bacterium. Implication in gastroduodenal diseases].
    Sobhani I; Vallot T; Mignon M
    Presse Med; 1995 Jan; 24(2):67-73, 75-6, 78-9. PubMed ID: 7899350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradication: A pilot empirical second-line rescue therapy.
    Mahmoudi L; Farshad S; Seddigh M; Mahmoudi P; Ejtehadi F; Niknam R
    Medicine (Baltimore); 2016 Oct; 95(42):e4410. PubMed ID: 27759625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No Helicobacter pylori, no Helicobacter pylori-associated peptic ulcer disease.
    Tytgat GN
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():39-42. PubMed ID: 7495941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial.
    Svoboda P; Kantorová I; Ochmann J; Doubek J; Kozumplík L; Marsová J
    Hepatogastroenterology; 1997; 44(15):886-90. PubMed ID: 9222709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating
    Ashraf AA; Gamal SM; Ashour H; Aboulhoda BE; Rashed LA; Harb IA; Abdelfattah GH; El-Seidi EA; Shawky HM
    Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G461-G476. PubMed ID: 34431405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
    Hu FL; Jia JC; Li YL; Yang GB
    J Int Med Res; 2003; 31(6):469-74. PubMed ID: 14708410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management of Helicobacter pylori infections in the elderly.
    Salles N; Mégraud F
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):845-56. PubMed ID: 17914918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy for Helicobacter pylori eradication: role of lansoprazole shown in vitro.
    Mégraud F
    J Clin Gastroenterol; 1995; 20 Suppl 1():S24-7. PubMed ID: 7673610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current regimens for treatment of Helicobacter pylori infection.
    Harris A
    Br Med Bull; 1998; 54(1):195-205. PubMed ID: 9604443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gastric biology of Helicobacter pylori.
    Sachs G; Weeks DL; Melchers K; Scott DR
    Annu Rev Physiol; 2003; 65():349-69. PubMed ID: 12471160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Reduction in Gastric Atrophy after
    Niikura R; Hayakawa Y; Hirata Y; Ogura K; Fujishiro M; Yamada A; Ushiku T; Konishi M; Fukayama M; Koike K
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and gastric or duodenal ulcer.
    Prescrire Int; 2016 Jan; 25(167):18-23. PubMed ID: 26942258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
    Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Apr; 21(16):5032-8. PubMed ID: 25945019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of antibiotic-resistant
    Alihosseini S; Ghotaslou R; Heravi FS; Ahmadian Z; Leylabadlo HE
    J Chemother; 2020 Oct; 32(6):273-285. PubMed ID: 32657237
    [No Abstract]   [Full Text] [Related]  

  • 19. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neither 10- nor 14-Day Sequential Treatment is better than Standard Triple Therapy for Helicobacter Pylori Eradication.
    Warrington E; López-Román O; Tirado Montijo R; Urbina R; Cruz-Correa M; Toro DH
    P R Health Sci J; 2016 Dec; 35(4):203-208. PubMed ID: 27898166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.